Practice question

Answer the question and get instant feedback.

Moderateampicillin‑sulbactam or ceftriaxone) plus macrolide is recommended; a respiratory fluoroquinolone monotherapy is an alternative. Macrolide alone (B) or doxycycline alone (E) are insufficient. Ceftriaxone alone (C) lacks atypical coverage. Adding vancomycin (D) is unnecessary without MRSA risk."Respiratory Medicine"moderate"

A 59-year-old with community-acquired pneumonia requires hospitalization (non-ICU). No MRSA/Pseudomonas risks. Recommended empiric therapy?

Educational content. Not a substitute for clinical judgement or local policy.